As the weight loss effects from Saxenda is lesser than Ozempics, the risk of developing loss of fats from the face from Saxenda is also expected to be lower
dulaglutide) comparisons among 125,336 adults with type 2 diabetes initiating a GLP-1 RA and found no difference in the rate of sight-threatening diabetic retinopathy between the different GLP-1 RA agents
Conquer fatigue by delaying muscle soreness so you can train longer
Given the prevalence of cardiovascular disease, type 2 diabetes, chronic kidney disease, and metabolic syndrome, it seems plausible that GLP1s reduce all-cause mortality
Consult a healthcare provider before making changes
While injections like Zepbound and Wegovy may prompt quick success, oral options appeal through daily intake ease and independence from injections, with Foundayo offering further flexibility in protocol